New tablet for gout and high uric acid
Part of Bones, joints & muscles, Kidney & urinary clinical trials.
This trial tests a new tablet (HR091506) for adults with gout and high uric acid. It aims to lower uric acid levels and reduce gout attacks, especially for people with more severe gout (like tophi or frequent attacks).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with gout and have high uric acid (above 8 mg/dL) on two separate tests.
- You have tophi (uric acid lumps under the skin), chronic joint damage from gout, or frequent gout attacks.
- You are willing to use birth control during the study and sign a consent form.
- You have not had a gout attack in the last 4 weeks, and you do not have serious heart disease, cancer, or poorly controlled health conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental tablet (SHR4640) added to the standard gout medicine febuxostat (40 mg daily) for people whose uric acid remains too high despite febuxostat alone. The goal is to see if the combination lowers uric acid more effectively and safely.
This trial tests a new tablet called BR2251 for people with gout and high uric acid. It aims to lower uric acid levels and manage gout symptoms.
This trial tests a new medicine called tigulixostat against febuxostat, a standard gout treatment, to see which works better at lowering uric acid levels. You may qualify if you have gout with high uric acid and have not had a gout flare in the last month.
This trial tests a new tablet (F-02-2-Na) to see if it's safe and how the body processes it. It's for healthy volunteers and people with high uric acid levels who may need long-term treatment.
This trial tests whether a tart cherry effervescent tablet can help lower uric acid levels in people who have high uric acid but have never had a gout attack. High uric acid can lead to gout and other health problems, so finding a safe way to lower it might help prevent these complications.
This study tests if a new drug, ABP-671, can safely lower high uric acid levels in people with chronic kidney disease. It may help reduce gout attacks and kidney damage.
Hear when a new Gout With Hyperuricemia in Adults trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.